Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases

Details for Australian Patent Application No. 2005249231 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Van Gestel, Jozef Frans Elisabetha; Andries, Koenraad Jozef Lodewijk Marcel

Agent Shelston IP

Pub. Number AU-B-2005249231

PCT Pub. Number WO2005/117875

Priority 04102402.7 28.05.04 EP

Filing date 24 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 11 November 2010

International Classifications

A61K 31/47 (2006.01) - Quinolines

Event Publications

9 November 2006 PCT application entered the National Phase

  PCT publication WO2005/117875 Priority application(s): WO2005/117875

11 November 2010 Application Accepted

  Published as AU-B-2005249231

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249232-Method of stabilizing proteins

2005249220-Locking assembly and dispensing cartridge comprising the same